ERBB2 and breast carcinoma: Lastly, the EPHA2/ephrin-A1 signaling axis in regulating glutamine metabolism in HER2-positive breast cancer has been explored, with findings suggesting that ephrin-A1 loss leads to upregulated glutamine metabolism and lipid accumulation, enhancing tumor growth [106].